Medical Industry News Archive

Click here to search our archive

Print using browser

URGENT MEDICINE RECALL: SANDOZ CEFPODOXIME 40mg/5ml Reg No A39/20.1.1/0397 (50ml and 100ml pack sizes)
Sandoz SA (Pty) Ltd in collaboration with the Medicines Control Council are initiating a Class 2, Type B recall on all batches of Sandoz Cefpodoxime 40mg /5ml (50ml and 100ml pack sizes).

Sandoz Cefpodoxime 40mg/5ml powder for oral suspension is an antibiotic used for short- term treatment of lower and upper respiratory tract infections in infants, children and adults.

The product is being recalled due to lower than expected efficacy, high unknown impurities, discolouration and formation of brownish agglomerates on certain batches of Sandoz Cefpodoxime 40mg/5ml tested during stability monitoring.

Use of the product may lead to weakened patient therapy through insufficient anti-infective treatment resulting in: a patient being contagious to others for a longer time, the development and spread of resistant bacterial strains, and significant therapeutic difficulties in eradication of respective bacteria.

In the interest of patient safety, Sandoz SA (Pty) Ltd request that you immediately return all batches of Sandoz Cefpodoxime 40mg/5ml stock without delay to your supplying wholesaler or distributor for full credit.
Sandoz SA (Pty) Ltd would like to thank you for your co-operation and apologise for any inconvenience caused.

Should you have any enquiries in this regard kindly contact the Sandoz Customer Call Centre 0861 SANCAL or 0861 726 225 during office hours and a technical support 24 hour call no 0768114744.

For full prescribing information please refer to package insert approved by Medical Regulatory Authority

Sandoz SA (Pty) Ltd PO Box 154, Isando 1600 Kempton Park, Gauteng South Africa Tel Fax +27 (0) 11 394 3084    Reg No: 1990/001979/07
Directors: R-A Bassoul (Canadian) J-C Dubos (French) M.M Paleja (Singaporean)  
A Novartis Company

You need to be logged in to see more details. Register Now!

Click here for more information .....
Contact: Carla Urbani-Smith, (Responsible Pharmacist)
Telephone: +27 (0) 11 929 9000
Date: Tuesday, February 14, 2012

Archive News Headlines
Boehringer Ingelheim - Out of stock - Co-Pritor 80/12.5 mg tablets (telmisartan, hydrochlorothiazide)
Adcock Ingram launch Roznal OTC Capsules (lansoprazole)
Aspen - launch - Duodart Capsules (dutasteride 0,5 mg, tamsulosin hydrochloride 0,4 mg)
Aspen - Out of Stock - Betnesol-N Eye, Ear and Nose Drops (betamethasone, neomycin sulphate)
Equity Pharmaceuticals launch Fycompa 2mg, 4 mg, 6 mg, and 8 mg tablets (perampanel)
Tara Pharmaceuticals launch Progast Liquid 50ml
Adcock Ingram - Out of stock - Atropine Eye Drops 5ml (atropine)
Name and entity change - Flordis South Africa
Adcock Ingram - Back in Stock - Estro-Pause N Tablets (oestradiol valerate, norethisterone)
Aspen - Out of Stock - Ativan SL 1 mg and Ativan 2,5 mg tablets (Lorazepam)
Sanofi discontinue Tranxene 15 mg tablets (dipotassium clorazepate)
Adcock Ingram - Out of Stock - Estalis 50/140 (oestradiol, norethisterone)
Aspen - Back in Stock - Normison 10 mg and 20 mg Capsules (temazepam)
Aspen - Back in Stock - Fortfen 100 SR Capsules (diclofenac sodium)
Aspen - Out of Stock - Aspen Quinine 300 mg tablets (quinine sulphate)
Aspen - Betanoid 0.5 mg tablets (betamethasone)
Litha Pharma - Out of Stock - Pur-Bloka 10 mg tablets (propranolol hydrochloride)
Takeda (Pty) Ltd and Adcock Ingram Healthcare co-promoting Topzole (pantoprazole)
Tara Pharmaceuticals launch Flugon 365 Enduro Power 300gm
Litha Pharma - Lethyl 30 mg 1000's Tablets (phenobarbitone)